Top news of the week: 06.06.2022.
‘How do you decide?’: Cancer treatment’s CAR-T crisis has patients dying on a wait list
“And people are dying. About 20% of all our patients together are actually dying before they can get CAR-T,” said Krina Patel, director of the myeloma cell therapy program at MD Anderson.
Precision Oncology Co. Signs $1.325B Licensing Deal Trending Company
Repare Therapeutics Inc. shares traded more than 50% higher after the company reported it entered into a worldwide license and collaboration agreement with Roche AG for its anti-tumor drug ...
Seattle’s Sana Biotech Shifts Manufacturing to Bothell, Washington, Adds Key Leaders
Seattle-based Sana Biotechnology is moving on from its current Fremont, California manufacturing facility, inking a lease deal to develop a manufacturing plant in Bothell, Washington.
The curious case of a communist cancer drug
“Oncology never feels more to me like team science than in those instances.” Newly identified regulator in prostate cancer cells could serve as drug target for advanced tumors …
Upstream Bio Dives into Severe Asthma Space with $200M in Series A Financing
Upstream Bio is focusing its efforts on an experimental treatment for severe asthma licensed from Astellas Pharma.
Global Roundup: Memo Therapeutics Takes Aim at BKV Infections
Biopharma and life sciences organizations from across the globe provide updates on their pipelines and businesses.
A New Targeted Cancer Company To Watch
Jean Cui led the invention of Pfizer's Xalkori. Now she has her own company focusing on drug-resistant cancers, and it has raised $147 million.
Digital Technology in Clinical Trials Conference
Digital Technology in Clinical Trials